Extended Release Olanzapine (Zyprexa Relprevv®)

Extended Release Olanzapine (Zyprexa Relprevv®) is a long-acting, second-generation (atypical), injectable antipsychotic. Here is basic information about this medication. FDA-approved indications Schizophrenia Dosage Recommended dosing of extended release olanzapine based on correspondence to oral olanzapine doses A. First 8 weeks of treatment a) Target oral dose 10 mg/day: 210 mg/2 weeks or 405 mg/4 weeks b) Target oral […]

Haloperidol (Haldol® Decanoate)

Haldol® Decanoate is a brand name of a depot formulation of haloperidol which is a first-generation (“typical”) antipsychotic. Here is basic information about this medication. FDA-approved indications Treatment of schizophrenic patients who require prolonged parenteral antipsychotic therapy Dosage A. Initial dosage (given by deep IM injection every month) Switchover from oral dose to haloperidol decanoate […]

Ziprasidone (Geodon®)

Ziprasidone (US brand name Geodon® and generic) is a second-generation (“atypical”) antipsychotic. FDA-approved indications A. As an oral formulation 1. Schizophrenia 2. Acute treatment as monotherapy of manic or mixed episodes associated with bipolar I disorder 3. Maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate B. As an intramuscular injection […]

Lurasidone (Latuda®)

Lurasidone or Latuda® is a second-generation antipsychotic, manufactured by Sunovion and introduced in the US in 2010 for the acute treatment of schizophrenia. Note: This page and its related pages contain the full text of the chapter on lurasidone (Latuda) in my book, The Latest Antidepressants. This webpage will always have the most up-to-date version of that […]

Iloperidone (Fanapt®): Basic Information

Iloperidone (US brand name Fanapt®) is a second-generation (“atypical”) antipsychotic. FDA-approved indications Treatment of adults with schizophrenia Dosage Starting: 1 mg twice daily Target: 6–12 mg twice daily (achieved by dose increments of 1–2 mg twice daily) Maximum: 12 mg twice daily (24 mg/day) Please refer to Prescribing Information (see link below) for complete discussion […]

Clozapine (Clozaril®)

Clozapine (US brand names Clozaril®, Fazaclo® ODT, Versacloz®, and generic) is a second-generation (“atypical”) antipsychotic. Here is basic information about this medication. FDA-approved indications 1. Treatment resistant schizophrenia 2. Reducing suicidal behavior in patients with schizophrenia or schizoaffective disorder Dosage Starting: 12.5 mg once or twice daily, with or without food Titration: Increase the total daily dosage in increments […]

Cariprazine (Vraylar®)

Cariprazine (Vraylar®) is a second-generation (atypical) antipsychotic. Here is basic information about this medication. FDA-approved indications 1. Schizophrenia 2. Acute treatment of manic or mixed episodes associated with bipolar I disorder. Dosage Schizophrenia Starting: 1.5 mg/day Recommended: 1.5–6 mg/day Bipolar Mania Starting: 1.5 mg/day Recommended: 3–6 mg/day Please refer to Prescribing Information (see link below) for […]

Brexpiprazole (Rexulti®)

The United States Food and Drug Administration (FDA) approved   brexpiprazole (brand name “Rexulti®”) in July 2015 for two indications:   the treatment of schizophrenia and as adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD). Rexulti® is manufactured by Otsuka Pharmaceutical Company Ltd and co-marketed with H. Lundbeck A/S. Pharmacological effects 1. Partial agonist at […]

Asenapine (Saphris®)

Asenapine (US brand name Saphris®) is a second-generation (“atypical”) antipsychotic. FDA-approved indications 1. Schizophrenia 2. Acute treatment of manic and mixed episodes associated with bipolar I disorder (monotherapy) 3. Acute treatment of manic and mixed episodes associated with bipolar I disorder (adjunctive to lithium or valproate) Dosage Schizophrenia – acute treatment in adults Starting: 5 […]

Aripiprazole (Abilify®)

Aripiprazole (US brand name Abilify® and generic Aripiprix, zolonda) is a second-or third generation (atypical) antipsychotic. FDA-approved indications A. Oral 1. Schizophrenia 2. Acute treatment of manic and mixed episodes associated with bipolar I disorder 3. Adjunctive treatment of major depressive disorder 4. Irritability associated with autistic disorder 5. Treatment of Tourette’s disorder B. Injectable […]

Haloperidol

Haloperidol (US brand name Haldol® and generic) is a first-generation (“typical”) antipsychotic. Here is basic information about this medication. Oral Haloperidol (Tablets, Oral concentrate) FDA-approved indications 1. Management of manifestations of psychotic disorders 2. Control of tics and vocal utterances of Tourette’s Disorder in children and adults 3. Treatment of severe behavior problems in children of combative, […]

Learning inforgraphs

Find more education infographics on e-Learning Infographics Find more education infographics on e-Learning Infographics Find more education infographics on e-Learning Infographics Find more education infographics on e-Learning Infographics Find more education infographics on e-Learning Infographics Find more education infographics on e-Learning Infographics

mood dys-regulation disorder: Diagnosis and Management

Professor Dr. Heba El Shehawi,Professor of Child Psychiatry,,Institute of Psychiatry,Ain Shams University,Egypt. She is giving a full lecture about mood dysregulation disorders among children, diagnosis and management. Professor Heba has a full clinical experience in the field and she is running a daily child psychiatry clinic managing different disorder.

Evolution of the brain: Psychiatrist and Mind

Professor Ahmed Okasha, gives a full lecture about psychiatry, mind and the brain. Evolution of the human brain from psychiatric point of view. Lecture is mostly in arabic for everyone working in the field of psychiatry, psychology , medicine and anthropology as well. It is a global view , comparative , analyzing and critical thinking. […]